MedTrace Logo

Esmolol Infusion During Laminectomy: Effect on Quality of Recovery

NCT01179113 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 33

Last updated 2016-11-02

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the effects of esmolol, a drug which is commonly administered during surgery to help control blood pressure and heart rate, on postoperative pain levels and requirements for pain medication.

Conditions

  • Laminectomy

Interventions

DRUG

Esmolol

Esmolol group: Will receive 0.5 mg/kg IV bolus of esmolol during induction, and an infusion of esmolol at 0.3 mg/kg/hr intraoperatively.

DRUG

Saline

Loading: an equivalent volume for the Esmolol group Infusion: an equivalent volume for the Esmolol group

Sponsors & Collaborators

  • Cedars-Sinai Medical Center

    lead OTHER

Principal Investigators

  • Roya Yumul, MD, PhD · Cedars-Sinai Medical Center

  • Roya Yumul, MD., PhD · Cedars-Sinai Medical Center

Study Design

Allocation
RANDOMIZED
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-06-30
Primary Completion
2015-05-31
Completion
2015-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01179113 on ClinicalTrials.gov